US Value Strategy

10 Jun 2020
The US Value strategy uses fundamental criteria to select stocks from a pool of large capitalisation US stocks. The selection criteria involve two main fundamental concepts being 1. Earnings Sustainability and 2. Return on Capital Employed. These criteria are combined with the earnings yield of the company to produce a Rivkin Value rank.

Latest Update – 10 June 2020

It is time to rebalance the the US Value Strategy. Following the most recent value ranking as of the close on Tuesday, we currently hold just four of the top ten US value stocks, meaning we need to sell the six stocks that have dropped off the list. The required sells include;  Capri Holdings (CPRI), Kohls Corp (KSS), Nordstrom (JWN), HP Inc. (HPQ), Snap-on Inc. (SNA), and Cardinal Health (CAH).

We generally recommend using the sales proceeds to take up an allocation in the new stocks. For the month of June, the stocks to add include; Qualcomm (QCOM), Lockheed Martin (LMT), Cisco Systems (CSCO), Amgen Inc. (AMGN), MXIM Integrated (MXIM), and Dollar Tree Inc. (DLTR). 

As a reminder, this strategy rebalances on the 10th of each month (or the next business day if the 10th is a non-trading day). For specific details of closed trades, please see our closed trades page.

For historical trade updates please click here.

Stock codeStock nameRankQtyEntry dateEntry priceCurrent priceCurrent valueReturn percentage
AbbVie Inc
5911 May 20$83.96$99.14$5,849.2618.08%
Amgen Inc
2210 Jun 20$224.90$255.12$5,612.6413.44%
Cisco Systems
10410 Jun 20$48.05$45.70$4,752.80(4.89%)
Dollar Tree Inc
5410 Jun 20$92.58$93.39$5,043.060.87%
Electronic Arts Inc
4211 May 20$116.62$135.22$5,679.2415.95%
Fox Corp - Class A
19211 May 20$26.00$26.93$5,170.563.58%
Lockheed Martin
1210 Jun 20$408.56$360.42$4,325.04(11.78%)
Altria Group Inc
13611 May 20$36.74$39.24$5,336.646.80%
Maxim Integrated
8210 Jun 20$60.66$59.69$4,894.58(1.60%)
Qualcomm Inc
5510 Jun 20$89.75$89.78$4,937.900.03%

*Quantities are based on investing US$5,000 per stock on the entry date
**All dollar values are in US dollars, and therefore returns are calculated as a US dollar return. Depending on whether or not you use hedging to manage your currency, exposure will determine whether you need to adjust returns to account for exchange rate effects.

US Value Strategy

Our strategy selects stocks from the S&P 500 as well as the Nasdaq 100 indices. This produces a pool of approximately 500-600 stocks to choose a portfolio from (depending on the overlap between the two indices). The Value ranking process narrows this list down to just ten stocks which form the recommended portfolio for investors following this strategy.

As with Rivkin’s other strategies, not all of the trades will be a winner, but the statistics should be in the investors favour such that over the long term, we expect a market-beating return. According to the back-testing, we expect 59% of trades to be winners, and we expect an average profit per winning trade of 12.5%. On the other side, the losing trades have an average loss per trade of just 9.24%.

How To Follow This Strategy

Rivkin’s strategies are designed to be as easy as possible for investors to follow. To follow the US Value strategy, investors need to buy the stocks in the above table in equal weights. Weights can drift over time as stock prices move, but we only recommend re-balancing stock weights if they stray too far from the target weight (10% per stock). The stock volumes shown in this table are based on a $5,000 investment per stock which produces a $50,000 portfolio. Being a US strategy, this is priced in US dollars and therefore, to get the Australian dollar value, the current exchange rate should be applied.

Once per month, the list of stocks will be updated in what we call a ‘re-balance’. This means investors will need to look at the new list and sell any stocks that are no longer on the list. After these stocks are sold, the new stocks from the current table can be bought.

About The Strategy

The US Value strategy was developed by Rivkin during 2017 and was rolled out as a strategy to clients in February 2018. Extensive back-testing was done to create and refine the strategy, and it is this back-testing that we rely on to give us increased confidence about future expectations. Please click here to find out more about the strategy.

Rivkin does not ever provide financial advice. Please consider your own circumstances before purchasing any of our products or acting on our general advice, for any Rivkin product or recommendation.



You need to be a Strategies user to comment on this post. Click here and become premium now!

Peter W.

The BMY advice is unclear – are we selling the entire holding or just down to 10%? Also we are left with BRISTOL MYERS SQUIBB CO VALUE RT- CVR Rights – currently trading at $US 2.91 – should we also sell these

William O.

Hi Peter,
Sorry for this oversight, the advice has been corrected. We are selling the full BMY position.

Peter W.

including the rights?

William O.

Hi Peter,
I have made a further update to the text. We will sell these rights from the model account but members can decide to keep them if they wish. It is a bit of a lottery ticket as to whether they will pay off in the future (depends on performance of certain CELG assets bought by BMY). If they do pay off, you will just be automatically paid some amount in the future for them. Otherwise, if you want the certainty of value today, just sell them on market.

We are glad you liked it

For your convenience, this will appear under your Saved articles in the top menu.